Business Description
Karolinska Development AB
ISIN : SE0002190926
Share Class Description:
FRA:2I9: Class BCompare
Compare
Traded in other countries / regions
KDEV.Sweden0P3C.UK2I9.GermanyKDEVF.USA IPO Date
2018-07-13Description
Karolinska Development AB is a life science investment company. It is focused on identifying breakthrough medical innovations in the Nordic region. It selects commercially attractive medical innovations, develops innovations to the stage where the return on investment can be achieved, and commercializes the innovations through the sale of companies or out-licensing of products. The company focused on profiles namely Aprea Therapeutics; Modus Therapeutics; BioArctic; Umecrine Cognition; and OssDsign.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 16.66 | |||||
| Equity-to-Asset | 0.99 | |||||
| Debt-to-EBITDA | 0.42 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 14.49 | |||||
| Beneish M-Score | -2.07 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -18.6 | |||||
| 3-Year EPS without NRI Growth Rate | 24.6 | |||||
| 3-Year FCF Growth Rate | 17.9 | |||||
| 3-Year Book Growth Rate | 4.6 | |||||
| Future 3-5Y EPS without NRI Growth Rate | -9.01 | |||||
| Future 3-5Y Total Revenue Growth Rate | -0.21 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.83 | |||||
| 9-Day RSI | 50.4 | |||||
| 14-Day RSI | 48.68 | |||||
| 6-1 Month Momentum % | -16.49 | |||||
| 12-1 Month Momentum % | -30.78 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.06 | |||||
| Quick Ratio | 4.06 | |||||
| Cash Ratio | 3.68 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -10.9 | |||||
| Shareholder Yield % | -0.77 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -1508.36 | |||||
| Net Margin % | -1519.01 | |||||
| FCF Margin % | -1397.01 | |||||
| ROE % | -2.3 | |||||
| ROA % | -2.28 | |||||
| ROIC % | -2.41 | |||||
| ROC (Joel Greenblatt) % | 205.04 | |||||
| ROCE % | 0.37 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 152.86 | |||||
| PB Ratio | 0.24 | |||||
| Price-to-Tangible-Book | 0.24 | |||||
| EV-to-EBIT | 54.94 | |||||
| EV-to-Forward-EBIT | -10.74 | |||||
| EV-to-EBITDA | 45.13 | |||||
| EV-to-Forward-EBITDA | -10.74 | |||||
| EV-to-Revenue | 135.75 | |||||
| EV-to-Forward-Revenue | 134.2 | |||||
| EV-to-FCF | -9.56 | |||||
| Price-to-Projected-FCF | 0.34 | |||||
| Price-to-Median-PS-Value | 1.08 | |||||
| Price-to-Net-Current-Asset-Value | 7.56 | |||||
| Price-to-Net-Cash | 7.56 | |||||
| Earnings Yield (Greenblatt) % | 1.82 | |||||
| FCF Yield % | -9.02 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Karolinska Development AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.167 | ||
| EPS (TTM) (€) | -0.01 | ||
| Beta | 0.56 | ||
| Volatility % | 45.03 | ||
| 14-Day RSI | 48.68 | ||
| 14-Day ATR (€) | 0.006939 | ||
| 20-Day SMA (€) | 0.075855 | ||
| 12-1 Month Momentum % | -30.78 | ||
| 52-Week Range (€) | 0.0613 - 0.1728 | ||
| Shares Outstanding (Mil) | 269.83 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Karolinska Development AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Karolinska Development AB Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Karolinska Development AB Frequently Asked Questions
What is Karolinska Development AB(FRA:2I9)'s stock price today?
The current price of FRA:2I9 is €0.08. The 52 week high of FRA:2I9 is €0.17 and 52 week low is €0.06.
When is next earnings date of Karolinska Development AB(FRA:2I9)?
The next earnings date of Karolinska Development AB(FRA:2I9) is 2025-02-14 Est..
Does Karolinska Development AB(FRA:2I9) pay dividends? If so, how much?
Karolinska Development AB(FRA:2I9) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers